Groundbreaking: First-Ever HCC RAF Score Accessible Through REST API
First-Ever HCC RAF Score Accessible Through REST API
Check Now
Image depicting the concept of elevating provider support and enhancing concurrent coding for risk adjustment in healthcare.
Elevate Provider Support:
Enhance Your Concurrent Coding
for Risk Adjustment
Check Now
ICD10 PCS Codes 3 3E 3E0 3E04

ICD-10-CM Diagnosis Code

Central Vein(3E04)

  • 3E04 Central Vein
    • 3E040 Open
      • 3E0400 Antineoplastic
        • 3E04002 High-dose Interleukin-2
        • 3E04003 Low-dose Interleukin-2
        • 3E04005 Other Antineoplastic
        • 3E0400M Monoclonal Antibody
        • 3E0400P Clofarabine
      • 3E0401 Thrombolytic
        • 3E04016 Recombinant Human-activated Protein C
        • 3E04017 Other Thrombolytic
      • 3E0402 Anti-infective
        • 3E04028 Oxazolidinones
        • 3E04029 Other Anti-infective
      • 3E0403 Anti-inflammatory
        • 3E0403Z No Qualifier
      • 3E0404 Serum, Toxoid and Vaccine
      • 3E0406 Nutritional Substance
      • 3E0407 Electrolytic and Water Balance Substance
      • 3E040F Intracirculatory Anesthetic
      • 3E040G Other Therapeutic Substance
        • 3E040GC Other Substance
        • 3E040GN Blood Brain Barrier Disruption
      • 3E040H Radioactive Substance
      • 3E040K Other Diagnostic Substance
      • 3E040N Analgesics, Hypnotics, Sedatives
      • 3E040P Platelet Inhibitor
      • 3E040R Antiarrhythmic
      • 3E040T Destructive Agent
      • 3E040V Hormone
        • 3E040VG Insulin
        • 3E040VH Human B-type Natriuretic Peptide
        • 3E040VJ Other Hormone
      • 3E040W Immunotherapeutic
        • 3E040WK Immunostimulator
        • 3E040WL Immunosuppressive
      • 3E040X Vasopressor
    • 3E043 Percutaneous
      • 3E0430 Antineoplastic
        • 3E04302 High-dose Interleukin-2
        • 3E04303 Low-dose Interleukin-2
        • 3E04305 Other Antineoplastic
        • 3E0430M Monoclonal Antibody
        • 3E0430P Clofarabine
      • 3E0431 Thrombolytic
        • 3E04316 Recombinant Human-activated Protein C
        • 3E04317 Other Thrombolytic
      • 3E0432 Anti-infective
        • 3E04328 Oxazolidinones
        • 3E04329 Other Anti-infective
      • 3E0433 Anti-inflammatory
        • 3E0433Z No Qualifier
      • 3E0434 Serum, Toxoid and Vaccine
      • 3E0436 Nutritional Substance
      • 3E0437 Electrolytic and Water Balance Substance
      • 3E043F Intracirculatory Anesthetic
      • 3E043G Other Therapeutic Substance
        • 3E043GC Other Substance
        • 3E043GN Blood Brain Barrier Disruption
        • 3E043GQ Glucarpidase
        • 3E043GR Other Therapeutic Monoclonal Antibody
      • 3E043H Radioactive Substance
      • 3E043K Other Diagnostic Substance
      • 3E043N Analgesics, Hypnotics, Sedatives
      • 3E043P Platelet Inhibitor
      • 3E043R Antiarrhythmic
      • 3E043T Destructive Agent
      • 3E043V Hormone
        • 3E043VG Insulin
        • 3E043VH Human B-type Natriuretic Peptide
        • 3E043VJ Other Hormone
      • 3E043W Immunotherapeutic
        • 3E043WK Immunostimulator
        • 3E043WL Immunosuppressive
      • 3E043X Vasopressor
    • 3E04 Central Vein